|
BioReliance has extensive experience in the development and application of toxicological methodologies using rodent and other small laboratory animals. In addition to traditional toxicology studies, our scientific staff is recognized internationally for its experience in the successful management and performance of multidisciplinary biomedical and toxicological research projects.
With toxicology moving toward the cellular and molecular level, it's becoming necessary and beneficial to develop more sensitive assays with molecular endpoints. BioReliance is a leader in developing and providing preclinical safety studies for nucleic acid-based therapeutics, a class that includes gene therapies, viral oncolytics, DNA vaccines, and other gene-based products. Studies offered for these products include acute toxicity, repeat dose safety tests, and biodistribution studies.
Our mammalian toxicology services include:
- Repeated-Dose Studies
- Analytical Chemistry Services
- Studies for Nucleic Acid Based Therapeutics
(Download our four page transgenic
carcinogenicity brochure)
|
